調查批次:CHT2015-07 | 檢體寄出日期:2015-07-13 | 報告回收截止日期:2015-07-20 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
1.66 |
-0.34 |
-17.0 |
-2.1 |
-0.9 |
-71 |
1.13 |
-0.11 |
-8.9 |
-1.1 |
-0.5 |
-37 |
RH07b | RH07 | 7 |
2 |
3 |
2.33 |
0.33 |
16.5 |
2.1 |
0.9 |
69 |
1.27 |
0.03 |
2.4 |
0.3 |
0.9 |
10 |
RH14 | RH14 | 7 |
2 |
3 |
2.18 |
0.18 |
9.0 |
1.1 |
0.5 |
38 |
1.23 |
-0.01 |
-0.8 |
-0.1 |
0.5 |
-3 |
RH15 | RH15 | 7 |
2 |
5 |
1.90 |
-0.10 |
-5.0 |
-0.6 |
-0.2 |
-21 |
1.40 |
0.16 |
12.9 |
1.6 |
2.2 |
53 |
CL009 | CL009 | 3 |
2 |
5 |
1.57 |
-0.43 |
-21.5 |
-2.7 |
-1.1 |
-90 |
1.13 |
-0.11 |
-8.9 |
-1.1 |
-0.5 |
-37 |
CL010 | CL010 | 2 |
2 |
5 |
1.74 |
-0.26 |
-13.0 |
-1.6 |
-0.7 |
-54 |
1.20 |
-0.04 |
-3.2 |
-0.4 |
0.2 |
-13 |
CL012 | CL012 | 7 |
2 |
3 |
2.41 |
0.41 |
20.5 |
2.6 |
1.1 |
85 |
1.19 |
-0.05 |
-4.0 |
-0.5 |
0.1 |
-17 |
CL013 | CL013 | 4 |
2 |
5 |
1.79 |
-0.21 |
-10.5 |
-1.3 |
-0.5 |
-44 |
1.08 |
-0.16 |
-12.9 |
-1.6 |
-1.0 |
-53 |
CL015 | CL015 | 3 |
2 |
3 |
2.33 |
0.33 |
16.5 |
2.1 |
0.9 |
69 |
1.07 |
-0.17 |
-13.7 |
-1.7 |
-1.1 |
-57 |
Median of RIA Group |
1.90 |
1.19 |
||||||||||||||
Range of RIA Group |
1.57 - 2.41 |
1.07 - 1.40 |
||||||||||||||
Robust mean of RIA Group |
1.99 ( n = 9 ) |
1.18 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.37 |
0.10 |
||||||||||||||
CV of RIA Group |
18.6% |
8.5% |
||||||||||||||
Median of European RIA Labs |
1.83 ( n = 99 ) |
1.17 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.58 - 2.07 |
1.04 - 1.42 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 3 |
4 |
9 |
1.85 |
-0.15 |
-7.5 |
-0.9 |
0.2 |
-31 |
1.29 |
0.05 |
4.0 |
0.5 |
0.7 |
17 |
RH02c | RH02 | 7 |
4 |
1 |
1.56 |
-0.44 |
-22.0 |
-2.8 |
-1.1 |
-92 |
1.01 |
-0.23 |
-18.5 |
-2.3 |
-0.7 |
-77 |
RH06 | RH06 | 1 |
4 |
9 |
2.21 |
0.21 |
10.5 |
1.3 |
1.7 |
44 |
1.45 |
0.21 |
16.9 |
2.1 |
1.6 |
70 |
RH07a | RH07 | 2 |
4 |
2 |
1.74 |
-0.26 |
-13.0 |
-1.6 |
-0.3 |
-54 |
1.06 |
-0.18 |
-14.5 |
-1.8 |
-0.5 |
-60 |
RH12 | RH12 | 2 |
4 |
2 |
1.65 |
-0.35 |
-17.5 |
-2.2 |
-0.7 |
-73 |
1.00 |
-0.24 |
-19.4 |
-2.4 |
-0.8 |
-80 |
RH19 | RH19 | 2 |
4 |
2 |
1.71 |
-0.29 |
-14.5 |
-1.8 |
-0.4 |
-60 |
1.05 |
-0.19 |
-15.3 |
-1.9 |
-0.5 |
-63 |
RH20 | RH20 | 3 |
4 |
7 |
1.83 |
-0.17 |
-8.5 |
-1.1 |
0.1 |
-35 |
1.24 |
0.00 |
0.0 |
0.0 |
0.5 |
0 |
CL005 | CL005 | 7 |
4 |
9 |
2.22 |
0.22 |
11.0 |
1.4 |
1.8 |
46 |
1.44 |
0.20 |
16.1 |
2.0 |
1.5 |
67 |
CL006a | CL006 | 7 |
4 |
7 |
1.82 |
-0.18 |
-9.0 |
-1.1 |
0.0 |
-38 |
1.14 |
-0.10 |
-8.1 |
-1.0 |
-0.1 |
-33 |
CL008 | CL008 | 7 |
4 |
2 |
1.65 |
-0.35 |
-17.5 |
-2.2 |
-0.7 |
-73 |
1.01 |
-0.23 |
-18.5 |
-2.3 |
-0.7 |
-77 |
CL011 | CL011 | 0 |
4 |
13 |
2.00 |
0.00 |
0.0 |
0.0 |
0.8 |
0 |
1.20 |
-0.04 |
-3.2 |
-0.4 |
0.3 |
-13 |
CL014b | CL014 | 3 |
4 |
1 |
1.60 |
-0.40 |
-20.0 |
-2.5 |
-0.9 |
-83 |
0.97 |
-0.27 |
-21.8 |
-2.7 |
-0.9 |
-90 |
Median of CLIA Group |
1.78 |
1.10 |
||||||||||||||
Range of CLIA Group |
1.56 - 2.22 |
0.97 - 1.45 |
||||||||||||||
Robust mean of CLIA Group |
1.81 ( n = 12 ) |
1.15 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.23 |
0.19 |
||||||||||||||
CV of CLIA Group |
12.7% |
16.5% |
||||||||||||||
Median of European CLIA Labs |
2.01 ( n = 1020 ) |
1.24 ( n = 1026 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.63 - 2.18 |
1.01 - 1.34 |
||||||||||||||
Median of All Labs |
1.82 |
1.14 |
||||||||||||||
Range of All Labs |
1.56 - 2.41 |
0.97 - 1.45 |
||||||||||||||
Robust mean of All Labs |
1.89 ( n = 21 ) |
1.16 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.31 |
0.15 |
||||||||||||||
CV of All Labs |
16.4% |
12.9%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.00 |
1.24 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.62 - 2.18 |
1.01 - 1.34 |
||||||||||||||
Mean of All European Labs |
1.92 ( n = 1180 ) |
1.19 ( n = 1197 ) |
||||||||||||||
SD of All European Labs |
0.25 |
0.155 |
||||||||||||||
CV of All European Labs |
12.9% |
13.1% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.16 |
0.099 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-07-23